"NanoKnife" Shows Promising Results, But...


October 5, 2010

The Wall Street Journal

According to an article in the Wall Street Journal, "some doctors are raising concerns about a new cancer-treatment device that uses electrical jolts to zap tumors but that hasn't been through a large clinical trial to prove it's safe and effective in people." The device, a "NanoKnife," is currently being used in about 13 US hospitals and costs as much as $300,000 each. While some of the hospitals are aggressively promoting the device in ads and media presentations, the NanoKnife has only been tested on animals and a small number of human patients. There has not been randomized, controlled clinical trials which are considered the "gold-standard studies." Quoted in the article is Timothy Clark, MD, director of Interventional Radiology at Penn Presbyterian Medical Center. The device "has potential to treat cancers next to delicate structures," said Dr. Clark, but for the time being, says, "there's a paucity of clinical data." Read More